echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > TRANSFUSION: risk of early intravenous bolus of 2 g and 4 g of tranexamic acid in patients with severe traumatic bleeding compared with placebo: a secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial

    TRANSFUSION: risk of early intravenous bolus of 2 g and 4 g of tranexamic acid in patients with severe traumatic bleeding compared with placebo: a secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Traumatic injury deaths are the most common cause of death among youth and children worldwide, more common


    Figure 1: TAMPITI patient screening, registration, randomization, and analysis plot


    Figure 2: Differences in


    Figure 3: Cumulative probability of thromboembolic events in each intervention group

    Results suggested that there were 50 patients in the placebo group, 49 patients in the 2-g group, and 50 patients


     

    Original source:

    Spinella, PC, Bochicchio, K, Thomas, KA, Staudt, A, Shea, SM, Pusateri, AE, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.